Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.
about
Optimal usage of the GnRH antagonists: a review of the literatureScheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturationPretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.Early initiation of gonadotropin-releasing hormone antagonist in polycystic ovarian syndrome patients undergoing assisted reproduction: randomized controlled trial ISRCTN69937179.Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.Pretreatment of normal responders in fresh in vitro fertilization cycles: A comparison of transdermal estradiol and oral contraceptive pills.Should mild stimulation be the order of the day?Optimisation of the follicular phase in IVF/ICSIControlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee.British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice.A fresh look at the freeze-all protocol: a SWOT analysis.Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.Weekend-free scheduled IVF/ICSI procedures and single embryo transfer do not reduce live-birth rates in a general infertile population.The effect of an immediate frozen embryo transfer following a freeze-all protocol: a retrospective analysis from two centres.Scheduling GnRH antagonist cycles by a short course of oral estradiol administration during early follicular phase: a comparative study with non-scheduled cycles.The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol.Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.Comparison between the gonadotropin-releasing hormone antagonist protocol and the gonadotropin-releasing hormone agonist long protocol for controlled ovarian hyperstimulation in the first in vitro fertilization-embryo transfer cycle in an unspecifieComparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT
P2860
Q21245566-DA70AB60-8172-4376-9B49-C849E1F50B97Q34975523-57869C86-F310-4D49-9964-B024E186C6F2Q36235804-7FCD6B83-528A-4ADE-8370-C833B1D6183EQ36247244-CE27A464-35E4-40B6-B5EE-27D67592B74FQ36335451-A3F7FE5B-6ADA-4D3E-A2C5-BC4B64F0B1C0Q36434675-903AA1E8-C94C-42E7-BFAE-338E9A31B46BQ37362092-E0E4EB9C-C9CF-4E14-9EB4-F836E3F1C2BFQ37585144-FBBEB2F1-08C1-4EDC-BC43-ACDE81156C39Q37658023-901482AC-0C53-42E6-8C06-A0187322160EQ37709779-27E53DD3-0274-4DE0-B60B-F77DCFADC943Q38109225-98CAD94E-8DA5-4194-8C21-56648D22EAA0Q38297114-43230F52-C4E2-46C4-8ADC-C0F8994B6112Q38685318-80518AD6-32C9-4C03-9A54-13E7A6272D2DQ45343526-143A58BD-961C-4BE6-A474-9B76CB319ACAQ47757356-13A77E71-66B6-49B6-95F7-B691678A0362Q48542271-DA65F834-2D1D-4CDE-8208-863B3903E17CQ48578488-2765F9E0-A18D-473B-8296-E96A6B7EC369Q48604738-0E18B7FF-9EAD-46EF-8CA9-335F4FC9895FQ48664239-C47D20C2-1387-407A-9325-518DB091D336Q52653133-249EDC13-18B0-41BA-8E57-72C555315E15Q53228207-A47D3325-F4E2-4DC4-8369-C0D0E27AC24DQ55257463-BE2F2A71-1C95-49FC-A0D8-BDA02A0DFD0CQ57136766-D7B13692-13D7-4AC3-8F53-D64632169E72
P2860
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@en
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@nl
type
label
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@en
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@nl
prefLabel
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@en
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@nl
P2093
P1476
Oral contraceptive pretreatmen ...... les: an updated meta-analysis.
@en
P2093
Basil Tarlatzis
Christos Venetis
Efstratios Michaelis Kolibianakis
Georg Griesinger
Klaus Diedrich
P304
P356
10.1016/J.FERTNSTERT.2010.04.025
P407
P577
2010-05-26T00:00:00Z